Literature DB >> 2139576

Oncoprotein stability after tumour resection.

G Ong1, W Gullick, K Sikora.   

Abstract

The means by which oncogenes and their products activate malignant transformation are currently under intense investigation. However, published papers on experiments using human tumour material do not always report in detail their methods of collection or storage of the specimens. In order to assess the stability of oncogene encoded proteins following collection or storage of human tumour biopsies, we have examined the rate of decay of the c-myc, neu and EGF-receptor proteins. Solid tumours, containing amplified copies of each oncogene, were established in nude mice and the stability of the oncogene protein in portions of each tumour, left in phosphate buffered saline at room temperature for varying time intervals, was examined by immunoblotting. Intact EGF-receptor and neu oncoproteins were present even after 24 h under these conditions while the c-myc protein was apparently rapidly degraded after 20 min. These data demonstrate that oncogene products decay at different rates after tumour resection and that collection of human biopsies should take this into account in order to provide the basis for consistent measurements of protein expression.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2139576      PMCID: PMC1971374          DOI: 10.1038/bjc.1990.121

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  16 in total

1.  Transmission densitometry of stained nitrocellulose paper.

Authors:  R A Maciewicz; P J Knight
Journal:  Anal Biochem       Date:  1988-11-15       Impact factor: 3.365

2.  Expression of the c-erbB-2 protein in normal and transformed cells.

Authors:  W J Gullick; M S Berger; P L Bennett; J B Rothbard; M D Waterfield
Journal:  Int J Cancer       Date:  1987-08-15       Impact factor: 7.396

3.  Biology of the A-431 cell: a useful organism for hormone research.

Authors:  C M Stoscheck; G Carpenter
Journal:  J Cell Biochem       Date:  1983       Impact factor: 4.429

4.  Antibodies against a synthetic peptide as a probe for the kinase activity of the avian EGF receptor and v-erbB protein.

Authors:  R M Kris; I Lax; W Gullick; M D Waterfield; A Ullrich; M Fridkin; J Schlessinger
Journal:  Cell       Date:  1985-03       Impact factor: 41.582

5.  p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor.

Authors:  R M Hudziak; G D Lewis; M Winget; B M Fendly; H M Shepard; A Ullrich
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

6.  Expression of cellular oncogenes in human malignancies.

Authors:  D J Slamon; J B deKernion; I M Verma; M J Cline
Journal:  Science       Date:  1984-04-20       Impact factor: 47.728

7.  Expression of epidermal growth factor receptors on human cervical, ovarian, and vulval carcinomas.

Authors:  W J Gullick; J J Marsden; N Whittle; B Ward; L Bobrow; M D Waterfield
Journal:  Cancer Res       Date:  1986-01       Impact factor: 12.701

8.  Expression of ras proto-oncogene proteins in normal human tissues.

Authors:  M E Furth; T H Aldrich; C Cordon-Cardo
Journal:  Oncogene       Date:  1987-03       Impact factor: 9.867

9.  Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product.

Authors:  G I Evan; G K Lewis; G Ramsay; J M Bishop
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

10.  The protein encoded by the human proto-oncogene c-myc.

Authors:  G Ramsay; G I Evan; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

View more
  5 in total

1.  Expression of Bcl-2 and amplification of c-myc are frequent in basaloid squamous cell carcinomas of the esophagus.

Authors:  M Sarbia; C Loberg; M Wolter; J Arjumand; H Heep; G Reifenberger; H E Gabbert
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

2.  C-erbB-2 immunostaining: problems with interpretation.

Authors:  E W Kay; C J Walsh; M Cassidy; B Curran; M Leader
Journal:  J Clin Pathol       Date:  1994-09       Impact factor: 3.411

3.  HER2 (c-erbB-2) oncoprotein expression in colorectal adenocarcinoma: an immunohistological study using three different antibodies.

Authors:  A H Arnaout; P M Dawson; S Soomro; P Taylor; N A Theodorou; M Feldmann; B M Fendly; H M Shepard; S Shousha
Journal:  J Clin Pathol       Date:  1992-08       Impact factor: 3.411

Review 4.  Theranostic applications of antibodies in oncology.

Authors:  Emmy D G Fleuren; Yvonne M H Versleijen-Jonkers; Sandra Heskamp; Carla M L van Herpen; Wim J G Oyen; Winette T A van der Graaf; Otto C Boerman
Journal:  Mol Oncol       Date:  2014-03-21       Impact factor: 6.603

5.  Response to mitoxantrone in advanced breast cancer: correlation with expression of c-erbB-2 protein and glutathione S-transferases.

Authors:  C Wright; J Cairns; B J Cantwell; A R Cattan; A G Hall; A L Harris; C H Horne
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.